Also found in: Thesaurus, Medical, Wikipedia.
Related to carvedilol: Ramipril


 (kär-vā′dĭ-lôl′, -lōl′ -vĕd′ĭ-)
A beta-blocker drug, C24H26N2O4, used especially to treat congestive heart failure and hypertension.

[carve-, probably alteration of carba(zole), one of its constituents (carb(o)- + -azole) + (vaso)dil(ator) + -ol.]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.carvedilol - beta blocker that can reduce the progression of heart failure in individuals whose disease is not advanced
beta blocker, beta-adrenergic blocker, beta-adrenergic blocking agent, beta-blocking agent - any of various drugs used in treating hypertension or arrhythmia; decreases force and rate of heart contractions by blocking beta-adrenergic receptors of the autonomic nervous system


n carvedilol m
References in periodicals archive ?
Among the 611 patients (53%) treated with carvedilol, 2.
Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Carvedilol Tablets, 3.
In the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial, glucose metabolism was not affected when carvedilol was added in diabetic hypertensive patients, whereas it significantly deteriorated when metoprolol was added (19).
By 24 months, a significantly higher percentage of the patients on carvedilol were free from a first variceal bleed (87% vs.
Ruffolo played a leading role in the discovery and/or development of a number of now marketed products, including carvedilol (Coreg/Kredex/Dilatrend) for the treatment of congestive heart failure, acute MI and hypertension, dobutamine (Dobutrex) for heart failure, ropinerole (Requip) for Parkinson's Disease, and eprosartan (Teveten) for hypertension.
Food and Drug Administration has granted tentative approval for the Company's ANDA for Carvedilol Tablets, 3.
Carvedilol in particular showed signs of efficacy for preventing atrial arrhythmia in patients with ischemic heart disease in the Carvedilol Postinfarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.
Biovail Corporation (NYSE:BVF)(TSX:BVF) announced today it has acquired the rights to a novel formulation of eprosartan (Teveten(R)) and a formulation for an enhanced version of carvedilol (Coreg(R)) through the acquisition of the remaining interest in BNC-PHARMAPASS, LLC.
ATLANTA -- A new hormone therapy for postmenopausal symptoms also has a significant antihypertensive effect; the popular [beta]-blocker carvedilol comes in a once-daily formulation; and an analysis of more than 600 representative patients with hypertension quantified the potential for reducing coronary heart disease by controlling blood pressure and serum lipids.
COREG CR will utilize Flamel's proprietary Micropump(R) technology, which controls the delivery of carvedilol helping to maintain appropriate amounts of medicine in the body over a 24-hour span.
A study in 2003 in 3,029 patients with New York Heart Association class II-IV heart failure and an ejection fraction of less than 35% were randomized to 25 mg of carvedilol twice daily or 50 mg of metoprolol tartrate (Lopressor) twice daily.